FTXH Holdings Information

FTXH is an equity ETF with a total of 50 individual holdings. The top holdings are Merck & Co. stock at 7.53%, AbbVie at 7.18%, Johnson & Johnson at 6.93%, Eli Lilly and Company at 6.85%, and Bristol-Myers Squibb Company at 6.61%.

Total Holdings

Top 10 Percentage

52.27%

Asset Class

Equity

ETF Category

Health

Assets

1.04B

PE Ratio

22.50

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	MRK	Merck & Co., Inc.	7.53%	544,360
2	ABBV	AbbVie Inc.	7.18%	290,461
3	JNJ	Johnson & Johnson	6.93%	271,402
4	LLY	Eli Lilly and Company	6.85%	63,872
5	BMY	Bristol-Myers Squibb Company	6.61%	1,080,978
6	BIIB	Biogen Inc.	3.66%	175,621
7	VTRS	Viatris Inc.	3.58%	2,257,753
8	VRTX	Vertex Pharmaceuticals Incorporated	3.37%	67,972
9	CAH	Cardinal Health, Inc.	3.32%	147,276
10	REGN	Regeneron Pharmaceuticals, Inc.	3.25%	43,252
11	PFE	Pfizer Inc.	3.25%	1,219,007
12	AMGN	Amgen Inc.	3.16%	87,024
13	GILD	Gilead Sciences, Inc.	3.12%	226,097
14	INCY	Incyte Corporation	2.43%	208,588
15	JAZZ	Jazz Pharmaceuticals plc	2.41%	101,979
16	UTHR	United Therapeutics Corporation	2.39%	49,942
17	ILMN	Illumina, Inc.	2.22%	111,746
18	ZTS	Zoetis Inc.	1.80%	256,992
19	CRL	Charles River Laboratories International, Inc.	1.74%	64,890
20	EXEL	Exelixis, Inc.	1.69%	313,636
21	HALO	Halozyme Therapeutics, Inc.	1.58%	152,941
22	MEDP	Medpace Holdings, Inc.	1.48%	26,272
23	TXG	10x Genomics, Inc.	1.33%	201,352
24	BMRN	BioMarin Pharmaceutical Inc.	1.22%	192,620
25	TWST	Twist Bioscience Corporation	1.21%	98,876

Showing 25 of 50 holdings

Subscribe to see the full list

Activate Now

As of Sep 13, 2026